Autres langues Integrum AB

Actions

INTEG B

SE0009807266

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:57 25/04/2024			Varia. 5j.	Varia. 1 janv.
51,4 ^SEK	-16,29 %		-15,18 %	+12,60 %

26/03	Integrum (publ) conclut un accord commercial avec AMI Technologies pour introduire le système d'implants OPRATM en Israël	CI
29/02	Integrum AB (publ) annonce ses résultats pour le troisième trimestre et les neuf mois clos le 31 janvier 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Integrum: Anchoring its position as niche leader	11/04
Integrum expands its product offering into the Israeli market	26/03
Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel	26/03
Health economic study shows positive outcome using Integrum's OPRA[TM] Implant System over socket prostheses in transfemoral amputees	19/03
Integrum Q3 - In line and no estimate changes	01/03
A new record revenue quarter with 61% growth	29/02
Integrum AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	29/02
Integrum AB, Invitation to the Third Quarter 2023, 24 Results Presentation	26/02
Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation	23/02
Integrum has sold and delivered OPRA[TM] Implant Systems to a value of SEK 3.5 million to Center of Excellence in Ukraine	31/01
Integrum Sells and Delivers Opratm Implant Systems to A Value of SEK 3.5 Million to Center of Excellence in Ukraine	31/01
Integrum establishes Center of Excellence in Ukraine	20/12
Integrum AB Establishes Center of Excellence in Ukraine	20/12
Integrum's MDR certification is completed for the OPRA[TM] Implant System	15/12
Integrum Q2 - Alive and kicking	05/12
Record sales and profitability	04/12
Integrum AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	04/12
Integrum AB changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Integrum AB: Invitation to the Second Quarter 2023/24 Results Presentation	28/11
Integrum plans to submit a PMA application to the FDA for the use of OPRA in transhumeral amputations based on existing clinical data	13/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Integrum AB

Actions

INTEG B

SE0009807266

Autres langues

Filtres